* Glaukos Corp GKOS.N reported a quarterly adjusted loss
of 40
cents per share for the quarter ended December 31, higher than
the same quarter last year, when the company reported EPS of -63
cents. The mean expectation of fifteen analysts for the quarter
was for a loss of 38 cents per share. Wall Street expected
results to range from -60 cents to -22 cents per share.
* Revenue rose 28.1% to $105.50 million from a year ago;
analysts
expected $100.72 million.
* Glaukos Corp's reported EPS for the quarter was a loss
of 60
cents.
* The company reported a quarterly loss of $33.58 million.
* Glaukos Corp shares had risen by 7.1% this quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 2.2%
in the last three months.
* In the last 30 days, one analyst negatively revised an
earnings
estimate
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"
Wall Street's median 12-month price target for Glaukos Corp is
$162.00
This summary was machine generated from LSEG data February 20 at
11:19 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 -0.38 -0.40 Missed
Sep. 30 2024 -0.48 -0.28 Beat
Jun. 30 2024 -0.51 -0.52 Missed
Mar. 31 2024 -0.57 -0.70 Missed